Syndromatic Treatment and STD Symptoms

Syndromatic treatment refers to the practice of treating people for sexually transmitted diseases based on their symptoms. It is usually done in low-resource settings. In other words, it's used where the cost of testing is prohibitive or where it is difficult to get people to come back for test results. Unfortunately, there are two main problems with syndromatic testing.

  1. Many sexually transmitted diseases are asymptomatic. Many people with chlamydia, gonorrhea, herpes, and other STDs won't have symptoms for years. In fact, they may never have them at all.
  2. The symptoms of sexually transmitted diseases can be aggravatingly unspecific. A liquid discharge, in particular, can be caused by many different types of pathogens. That means that it can be very hard to figure out what the best treatment is. For that matter, it can be very hard to figure out what any effective treatment is.
Woman sitting in doctor's office
fstop123 / Getty Images

In the United States, STD testing is pretty widely available. That means syndromatic treatment is less common in this country. That's a good thing. Treating infections with the wrong antibiotics is not only ineffective. It may also increase the risk of developing antibiotic-resistant strains of the disease.

NOTE: The fact that it is so difficult to diagnose most STDs based on their symptoms is one of the reasons why some doctors refuse to diagnose individuals over the Internet. In these cases, it would be difficult to make such diagnoses accurately. That's why screening is so important. The only way to know whether you have an STD is to get tested for one. 

Syndromic Treatment Is Better Than Nothing

There are circumstances where syndromic treatment can be useful. In general, in areas where testing isn't available, syndromic treatment is better than no treatment. Syndromic treatment may also be cost-effective in countries that only provide screening for individuals who have symptoms. For example, a study in Taiwan found that it was far cheaper than standard testing. However, they only looked at the costs for people who had symptoms. They didn't investigate how many asymptomatic cases were being missed. 

When you take those missed cases into account, the evidence for syndromic treatment is bad. In Kenya, for example, researchers found that it missed many cases of STDs in high-risk women. It also led to large amounts of overtreatment for STDs that didn't actually exist. In other words, it was problematic in both directions. It failed to treat important infections while also giving drugs to women who didn't need them. These problems have been reported time and time again. 

In short, syndromic treatment is better than nothing. It's not better than any form of more reliable and universal screening program. 

Was this page helpful?
Article Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.